Category Archive: Studies

History of Donor Marijuana Use Doesn’t Harm Lung Transplants, May Improve Them

A lung being donated from someone with a history of marijuana use does not negatively effect the outcome of the lung transplant, and may in fact improve it. This is according to a new study published by the European Journal Cardio-Thoracic Surgery; it was published online by the U.S. National Institute of Health. For the …

Continue reading »

Study: Cannabinoids May Treat Neurogenic Lower Urinary Tract Dysfunction

Cannabinoids may provide a safe and effective treatment option for neurogenic lower urinary tract dysfunction. This is according to a study published in the British Journal of Urology International (BJUI); it was published online by the U.S. National Institute of Health. According to researchers, the study’s objective was; “To systematically review all available evidence on …

Continue reading »

Study: Cannabis a Potential Treatment Option for Insulin Resistance and Obesity-Related Diabetes

Activation of the cannabinoid 2 receptor – done naturally through the consumption of cannabis and cannabinoids – may be a potential treatment option for insulin resistance and obesity-related diabetes. This is according to new research out of the Institute of Biomedical Engineering at the Chinese Academy of Medical Science; the study was study published in …

Continue reading »

Study: Cannabinoids Play a Protective Role Against Colitis

Cannabinoids can have anti-inflammatory effects and can play a protective role in patients with colitis; colitis is in an inflammatory reaction in the colon which is often infection or autoimmune. This is according to a study published in the World Journal of Gastroenterology, and published online by the U.S. National Institute of Health. According to …

Continue reading »

Study: Cannabis Can Serve as an Aphrodisiac and Enhance Pleasure/Satisfaction

Cannabis can serve as an aphrodisiac as well as enhance pleasure and satisfaction during and following sex. This is according to a new study published by the journal Pharmacological Research. It’s been e-published ahead of print by the U.S. National Institute of Health. According to the study, which examined preclinical trials using human subjects, approximately …

Continue reading »

Study: Cannabinoids May Treat Chronic Inflammation

Cannabinoids may provide a treatment option for chronic inflammation, according to a new study published in the FASEB Journal, and published online by the U.S. National Institute of Health. “Cannabinoids apparently act on inflammation through mechanisms different from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs)”, states the study’s abstract. “As a class, the …

Continue reading »

Study: Cannabis Use Among “Baby Boomers” Up 71% Since 2006

Via New York University Press Release The recent legalization of recreational marijuana (cannabis) use in California, Colorado, and Washington reflect the sweeping changes in the attitudes and perceptions towards marijuana use in the United States. Eight states have voted in favor of legal recreational marijuana and 26 states in total allow medicinal marijuana. There is …

Continue reading »

Top 10 Cannabis Studies of 2016

For the fourth consecutive year, we take a look at the year’s top 10 cannabis-related studies. It’s been a big year for cannabis science. A plethora of studies have been released demonstrating its wide medical properties. Although it was a challenge, we’ve narrowed these down to the top 10, with two honorable mentions. These include …

Continue reading »

Studies: Magic Mushrooms Reduce Depression and Anxiety in Cancer Patients

By Kai Kupferschmidt, Science Magazine (republished with special permission) Could a psychedelic drug help people who are dying of cancer face their fears? Two long awaited studies suggest that the hallucinogenic compound in magic mushrooms, psilocybin, could do just that. “They are the most rigorous double-blind placebo-controlled trials of a psychedelic drug in the past …

Continue reading »

F.D.A. Approves New Phase 3 Studies for Ecstasy as PTSD Treatment

The Food and Drug Administration has given approval to Phase 3 clinical trials of MDMA (ecstasy) for the treatment of post traumatic stress disorder (PTSD). This is the final step before the potential approval of ecstasy as a prescription drug. The move comes after several successful Phase 2 studies of ecstasy, which included 130 PTSD …

Continue reading »

Page 1 of 41123...1020...Last Page »